Immunotechnology research in antibody engineering supported by grant
– Published 17 May 2024
A team led by Prof. Mats Ohlin of the Dept. of Immunotechnology has received a grant of 3 MSEK from Mrs. Berta Kamprad's Foundation to further develop antibodies for cancer therapy using co-called chimeric antigen receptor (CAR) technology.